1-6 of 6
Luca Rigodanza
Close
Sort by
Journal Articles

Impact of Mutational Burden and IPSS-M on Response to ESAs in Lower Risk Myelodysplastic Neoplasms

Marco Gabriele Raddi, Angela Consagra, Luca Rigodanza, Cristina Amato, Alessandro Sanna, Giorgio Mattiuz, Sven De Pourcq, Elena Tofacchi, Maria Diez-Campelo, Juan Carlos Caballero Berrocal, Sophie Park, Mathieu Meunier, Celia Orlando, Michaela Fontenay, Olivier Kosmider, Nicolas Chapuis, Uwe Platzbecker, Katharina Zoldan, Anne Sophie Kubasch, Valeria Santini
Journal: Blood
Blood (2023) 142 (Supplement 1): 4595.
https://doi.org/10.1182/blood-2023-189053
Published: 2023
Journal Articles

Improved Overall Survival Among Luspatercept Responders and Predictors of Response

Angela Consagra, Luca Lanino, Najla H Al Ali, Luis E. Aguirre, Zhuoer Xie, Onyee Chan, Gloria Andreossi, Luca Rigodanza, Alessandro Sanna, Marco Gabriele Raddi, Alison R. Walker, Andrew T. Kuykendall, Jeffrey Lancet, Eric Padron, David A Sallman, Francesco Restuccia, Alessandra Perego, Marta Ubezio, Bruno Fattizzo, Marta Riva, Alessia Campagna, Matteo Giovanni Della Porta, Valeria Santini, Rami S. Komrokji
Journal: Blood
Blood (2023) 142 (Supplement 1): 1871.
https://doi.org/10.1182/blood-2023-186279
Published: 2023
Journal Articles

Treatment of Elderly Patients with Higher Risk Myelodysplastic Syndromes with Oral Azacitidine

Valeria Santini, Cristina Amato, Sven De Pourcq, Roberta della Seta, Barbara Caciagli, Marco Gabriele Raddi, Angela Consagra, Luca Rigodanza, Giorgio Mattiuz, Marzia Defina, Sara Galimberti, Giacomo Maestrini, Alessandro Sanna
Journal: Blood
Blood (2023) 142 (Supplement 1): 6501.
https://doi.org/10.1182/blood-2023-190016
Published: 2023
Journal Articles

Characteristics and Distribution of Erythroid Progenitors and Precursors Correlate with Erythropoiesis Stimulating Agents (ESAs) Response in Lower Risk Myelodysplastic Syndromes

Marco Gabriele Gabriele Raddi, Sara Bencini, Benedetta Peruzzi, Roberto Caporale, Angela Consagra, Enrico Attardi, Luca Rigodanza, Cristina Amato, Alessandro Sanna, Alice Brogi, Elena Tofacchi, Margherita Cassari, Sven de Pourcq, Giorgio Mattiuz, Francesco Annunziato, Valeria Santini
Journal: Blood
Blood (2022) 140 (Supplement 1): 9777–9778.
https://doi.org/10.1182/blood-2022-157506
Published: 2022
Journal Articles

The Combination of Decitabine Plus Venetoclax Is an Active Salvage Therapy for AML Post HR-MDS Progressed during Treatment with Azacitidine Based Regimens

Angela Consagra, Alessandro Sanna, Marco Gabriele Raddi, Luca Rigodanza, Enrico Attardi, Cristina Amato, Margherita Cassari, Elena Tofacchi, Giorgio Mattiuz, Sven de Pourcq, Valeria Santini
Journal: Blood
Blood (2022) 140 (Supplement 1): 11738–11739.
https://doi.org/10.1182/blood-2022-169192
Published: 2022
Journal Articles

Treatment with Oral Azacitidine in Elderly Patients with Higher Risk Myelodysplastic Syndromes after Response to Subcutaneous Azacitidine

Valeria Santini, Cristina Amato, Barbara Caciagli, Angela Consagra, Luca Rigodanza, Sven de Pourcq, Margherita Cassari, Elena Tofacchi, Giorgio Mattiuz, Marco Gabriele Gabriele Raddi, Alessandro Sanna
Journal: Blood
Blood (2022) 140 (Supplement 1): 12313–12314.
https://doi.org/10.1182/blood-2022-169090
Published: 2022